SEATTLE, Oct. 3 /PRNewswire/ -- Immunex Corporation (Nasdaq: IMNX) will
release third quarter 2001 earnings on Wednesday, October 17, 2001, after the
close of U.S. financial markets. This announcement will be made available on
the Immunex website at http://www.immunex.com, and on PRNewswire's website at
http://www.prnewswire.com.
Additionally, Immunex executives will host a conference call and live
audio webcast at 2:00 p.m. PDT (5:00 p.m. EDT) on October 17th to discuss the
company's financial results. The dial-in number for the earnings call is
973-628-6885. The live webcast and replay can be accessed on the Immunex
website at http://www.immunex.com/investor_fs3.html. Replay of the webcast
will be available through October 24, 2001.
Immunex has also scheduled presentations at the following investor
conferences in October 2001. For information about available webcasts and
replays, visit the "Investor" page, "Events" section on the Immunex
Corporation website at http://www.immunex.com/investor_fs3.html. Conference dates
and locations are as follows:
UBS Warburg Global Life Sciences Conference
October 8-12, 2001
New York, NY
Salomon Smith Barney Health Care Conference
October 29-31, 2001
New York, NY
Immunex Corporation is a leading biopharmaceutical company dedicated to
improving lives through immune system science innovations.
Except for the historical information contained herein, this news release
contains forward-looking statements that involve substantial risks and
uncertainties. Among the factors that could cause actual results or timelines
to differ materially are risks associated with research and clinical
development, regulatory approvals, our supply capabilities and reliance on
third-party manufacturers, product commercialization, competition, litigation
and other risk factors listed from time to time in reports filed by Immunex
with the SEC, including but not limited to risks described under the caption
"Important Factors That May Affect Our Business, Our Results of Operations and
Our Stock Price" within our most recently filed Form 10-Q. The
forward-looking statements contained in this news release represent our
judgment as of the date of this release. Immunex undertakes no obligation to
publicly update any forward-looking statements. An electronic version of this
news release -- as well as additional information about Immunex of interest to
investors, customers, future employees and patients -- is available on the
Immunex home page at http://www.immunex.com.
SOURCE Immunex Corporation
 back to top
Related links:
http://www.immunex.com
Company News On-Call:
http://www.prnewswire.com/comp/434644.html
CONTACT:
press, Robin Shapiro, +1-206-389-4040, or
investors, Mark Leahy, +1-206-389-4363, both of Immunex
Corporation
|
